Loncar Cancer Etf Forecast - Daily Balance Of Power
| CNCR Etf | USD 12.49 0.12 0.95% |
Loncar Etf Forecast is based on your current time horizon.
Loncar |
| Previous Daily Balance Of Power | Daily Balance Of Power | Trend |
| (0.88) | (0.39) |
| Check Loncar Cancer Volatility | Backtest Loncar Cancer | Trend Details |
Loncar Cancer Trading Date Momentum
| On December 20 2024 Loncar Cancer Immunotherapy was traded for 12.09 at the closing time. The top price for the day was 12.21 and the lowest listed price was 11.87 . The trading volume for the day was 2.5 K. The trading history from December 20, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 1.00% . The trading delta at closing time against the current closing price is 3.01% . |
Balance of Power indicator was created by Igor Livshin to predict asset short term price movements or warning signals. If Balance of Power indicator is trended towards the high of its range it will signify that the bulls are in control. On the other hand when the BOP indicator is moving towards the lows of its range it signifies that the bears are in control. If the indicator move from a high positive range to a lower positive range it signifies that the buying pressure is decreasing. Conversely, if the indicator move from a low negative range to a higher negative range it signifies that the selling pressure is decreasing.
| Compare Loncar Cancer to competition |
Other Forecasting Options for Loncar Cancer
For every potential investor in Loncar, whether a beginner or expert, Loncar Cancer's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Loncar Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Loncar. Basic forecasting techniques help filter out the noise by identifying Loncar Cancer's price trends.Loncar Cancer Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Loncar Cancer etf to make a market-neutral strategy. Peer analysis of Loncar Cancer could also be used in its relative valuation, which is a method of valuing Loncar Cancer by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Loncar Cancer Immuno Technical and Predictive Analytics
The etf market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Loncar Cancer's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Loncar Cancer's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Loncar Cancer Market Strength Events
Market strength indicators help investors to evaluate how Loncar Cancer etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Loncar Cancer shares will generate the highest return on investment. By undertsting and applying Loncar Cancer etf market strength indicators, traders can identify Loncar Cancer Immunotherapy entry and exit signals to maximize returns.
Loncar Cancer Risk Indicators
The analysis of Loncar Cancer's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Loncar Cancer's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting loncar etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.63 | |||
| Standard Deviation | 2.09 | |||
| Variance | 4.38 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Loncar Cancer
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Loncar Cancer position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Loncar Cancer will appreciate offsetting losses from the drop in the long position's value.Moving together with Loncar Etf
| 0.87 | XLV | Health Care Select | PairCorr |
| 0.9 | VHT | Vanguard Health Care | PairCorr |
| 0.94 | IBB | iShares Biotechnology ETF | PairCorr |
| 0.89 | XBI | SPDR SP Biotech | PairCorr |
Moving against Loncar Etf
| 0.73 | ARKW | ARK Next Generation | PairCorr |
| 0.58 | IAUF | IShares | PairCorr |
| 0.5 | WTMF | WisdomTree Managed | PairCorr |
| 0.41 | BST | BlackRock Science Tech | PairCorr |
The ability to find closely correlated positions to Loncar Cancer could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Loncar Cancer when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Loncar Cancer - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Loncar Cancer Immunotherapy to buy it.
The correlation of Loncar Cancer is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Loncar Cancer moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Loncar Cancer Immuno moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Loncar Cancer can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Historical Fundamental Analysis of Loncar Cancer to cross-verify your projections. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
The market value of Loncar Cancer Immuno is measured differently than its book value, which is the value of Loncar that is recorded on the company's balance sheet. Investors also form their own opinion of Loncar Cancer's value that differs from its market value or its book value, called intrinsic value, which is Loncar Cancer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Loncar Cancer's market value can be influenced by many factors that don't directly affect Loncar Cancer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Loncar Cancer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Loncar Cancer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Loncar Cancer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.